Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.
2.

Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase.

Glaser KB, Li J, Aakre ME, Morgan DW, Sheppard G, Stewart KD, Pollock J, Lee P, O'Connor CZ, Anderson SN, Mussatto DJ, Wegner CW, Moses HL.

Mol Cancer Ther. 2002 Aug;1(10):759-68.

4.
5.

Mediation of Trypanosoma cruzi invasion by heparan sulfate receptors on host cells and penetrin counter-receptors on the trypanosomes.

Herrera EM, Ming M, Ortega-Barria E, Pereira ME.

Mol Biochem Parasitol. 1994 May;65(1):73-83.

PMID:
7935630
6.

An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.

Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB.

Anal Biochem. 1994 Feb 1;216(2):276-84.

PMID:
8179182
7.

TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.

Kutz SM, Higgins CE, Samarakoon R, Higgins SP, Allen RR, Qi L, Higgins PJ.

Exp Cell Res. 2006 Apr 15;312(7):1093-105. Epub 2006 Feb 7.

PMID:
16457817
8.

Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.

Samarakoon R, Higgins CE, Higgins SP, Kutz SM, Higgins PJ.

J Cell Physiol. 2005 Jul;204(1):236-46.

PMID:
15622520
9.
10.

Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.

Allen RR, Qi L, Higgins PJ.

J Cell Physiol. 2005 Apr;203(1):156-65.

PMID:
15372465
11.
12.

Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.

Chen YQ, Sloan-Lancaster J, Berg DT, Richardson MA, Grinnell B, Tseng-Crank J.

Thromb Haemost. 2001 Dec;86(6):1563-72.

PMID:
11776328
13.

Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.

Vivien D, Attisano L, Wrana JL, Massagué J.

J Biol Chem. 1995 Mar 31;270(13):7134-41.

14.

SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion.

Waghabi MC, Keramidas M, Calvet CM, Meuser M, de Nazaré C Soeiro M, Mendonça-Lima L, Araújo-Jorge TC, Feige JJ, Bailly S.

Antimicrob Agents Chemother. 2007 Aug;51(8):2905-10. Epub 2007 May 25.

15.
16.

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.

Ewen ME, Sluss HK, Whitehouse LL, Livingston DM.

Cell. 1993 Sep 24;74(6):1009-20.

PMID:
8402878
17.

Distinct roles of the intracellular domains of transforming growth factor-beta type I and type II receptors in signal transduction.

Okadome T, Yamashita H, Franzén P, Morén A, Heldin CH, Miyazono K.

J Biol Chem. 1994 Dec 9;269(49):30753-6.

18.

Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.

Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G.

J Cell Physiol. 1997 Aug;172(2):200-8.

PMID:
9258341
19.
20.

Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene.

Lu SL, Kawabata M, Imamura T, Miyazono K, Yuasa Y.

Biochem Biophys Res Commun. 1999 Jun 7;259(2):385-90.

PMID:
10362519

Supplemental Content

Support Center